Octagos Health, a Houston, TX-based provider of AI-driven cardiac device monitoring solutions, has secured $43M in Series B funding.

The round was led by Morgan Stanley Expansion Capital, with participation from Mucker Capital and other strategic investors. Funds will be used to enhance their platform and scale commercial operations.

With the new capital, CEO Dr. Shanti Bansal plans to advance Octagos Health's AI-driven cardiac monitoring solutions to improve patient outcomes and integrate seamlessly with electronic health records.

Octagos Health's platform offers continuous monitoring and data analysis for implantable cardiac devices, providing healthcare providers with actionable insights and customizable reports.